Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine
Clinical trial NCT06543914 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06543914
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-11-26
- Primary completion
- 2029-02-01
- Enrollment
- 1314
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.